💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$93.7B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 2/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | $1.73B | $14.55 | 1.46% |
| SPRY | ARS Pharmaceuticals, Inc. | $1.73B | $17.59 | 1.46% |
| QDEL | QuidelOrtho Corporation | $1.73B | $25.54 | 0.95% |
| CERT | Certara, Inc. | $1.72B | $10.62 | 4.73% |
| SDGR | Schrödinger, Inc. | $1.67B | $22.77 | 0.22% |
| JANX | Janux Therapeutics, Inc. | $1.56B | $26.38 | 1.15% |
| CLDX | Celldex Therapeutics, Inc. | $1.48B | $22.36 | 1.36% |
| ETNB | 89bio, Inc. | $1.46B | $9.98 | 1.29% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.44B | $66.34 | 1.42% |
| VERA | Vera Therapeutics, Inc. | $1.42B | $22.29 | 2.19% |
| LQDA | Liquidia Corporation | $1.42B | $16.60 | 9.93% |
| NTLA | Intellia Therapeutics, Inc. | $1.40B | $13.49 | 6.81% |
| TVTX | Travere Therapeutics, Inc. | $1.39B | $15.66 | 1.01% |
| VRDN | Viridian Therapeutics, Inc. | $1.38B | $16.96 | 1.01% |
| BHVN | Biohaven Ltd. | $1.37B | $13.43 | 2.75% |
| DVAX | Dynavax Technologies Corporation | $1.34B | $11.18 | 2.19% |
| SRPT | Sarepta Therapeutics, Inc. | $1.34B | $13.62 | 2.21% |
| HROW | Harrow Health, Inc. | $1.33B | $36.11 | 2.62% |
| OMCL | Omnicell, Inc. | $1.32B | $28.26 | 0.82% |
| DYN | Dyne Therapeutics, Inc. | $1.30B | $9.21 | 0.44% |
| ELVN | Enliven Therapeutics, Inc. | $1.27B | $21.56 | 1.42% |
| INVA | Innoviva, Inc. | $1.21B | $19.28 | 1.13% |
| MNKD | MannKind Corporation | $1.19B | $3.93 | 2.88% |
| PAHC | Phibro Animal Health Corporation | $1.18B | $29.23 | 0.31% |
| NVAX | Novavax, Inc. | $1.17B | $7.22 | 0.70% |
| USPH | U.S. Physical Therapy, Inc. | $1.14B | $75.03 | 0.12% |
| PRAX | Praxis Precision Medicines, Inc. | $1.13B | $55.41 | 0.45% |
| SANA | Sana Biotechnology, Inc. | $1.10B | $4.87 | 9.68% |
| OPK | OPKO Health, Inc. | $1.09B | $1.38 | 1.43% |
| ARDX | Ardelyx, Inc. | $1.06B | $4.42 | 0.11% |
| GPCR | Structure Therapeutics Inc. | $1.05B | $18.19 | 0.33% |
| IOVA | Iovance Biotherapeutics, Inc. | $1.05B | $3.13 | 25.70% |
| PCRX | Pacira BioSciences, Inc. | $1.04B | $22.43 | 1.17% |
| BLFS | BioLife Solutions, Inc. | $1.02B | $21.41 | 3.13% |
| COLL | Collegium Pharmaceutical, Inc. | $1.02B | $31.64 | 2.36% |
| GLYC | GlycoMimetics, Inc. | $1.01B | $15.71 | 2.76% |
| AKBA | Akebia Therapeutics, Inc. | $1.01B | $3.85 | 0.26% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.01B | $21.35 | 0.76% |
| MDXG | MiMedx Group, Inc. | $998.47M | $6.76 | 1.65% |
| SYRE | Spyre Therapeutics, Inc. | $995.23M | $16.49 | 0.86% |
| VERV | Verve Therapeutics, Inc. | $987.71M | $11.08 | 1.37% |
| RCUS | Arcus Biosciences, Inc. | $969.91M | $9.16 | 1.08% |
| IMNM | Immunome, Inc. | $963.23M | $11.07 | 2.31% |
| AVXL | Anavex Life Sciences Corp. | $954.10M | $11.17 | 0.09% |
| ORIC | ORIC Pharmaceuticals, Inc. | $950.25M | $11.15 | 0.81% |
| LENZ | LENZ Therapeutics, Inc. | $928.26M | $32.98 | 1.79% |
| PROK | ProKidney Corp. | $896.60M | $3.05 | 5.28% |
| CURLF | Curaleaf Holdings, Inc. | $894.37M | $1.17 | 5.65% |
| SNDX | Syndax Pharmaceuticals, Inc. | $887.15M | $10.31 | 5.96% |
| MLYS | Mineralys Therapeutics, Inc. | $869.44M | $13.34 | 2.06% |
| NRIX | Nurix Therapeutics, Inc. | $860.06M | $11.25 | 0.00% |
| SION | Sionna Therapeutics, Inc. | $839.25M | $19.02 | 9.06% |
| TRVI | Trevi Therapeutics, Inc. | $834.01M | $7.00 | 2.64% |
| CRMD | CorMedix Inc. | $823.19M | $11.06 | 1.10% |
| XERS | Xeris Biopharma Holdings, Inc. | $819.99M | $5.12 | 0.39% |
| GERN | Geron Corporation | $815.26M | $1.28 | 4.07% |
| NUVB | Nuvation Bio Inc. | $797.27M | $2.35 | 0.21% |
| VIR | Vir Biotechnology, Inc. | $792.10M | $5.73 | 3.80% |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $791.15M | $21.56 | 0.05% |
| KALV | KalVista Pharmaceuticals, Inc. | $789.77M | $15.81 | 1.61% |
| URGN | UroGen Pharma Ltd. | $783.57M | $16.96 | 9.70% |
| ANAB | AnaptysBio, Inc. | $770.06M | $26.21 | 0.15% |
| NAGE | Niagen Bioscience Inc | $744.37M | $9.45 | 2.38% |
| MAZE | Maze Therapeutics, Inc. | $741.92M | $16.94 | 1.68% |
| STOK | Stoke Therapeutics, Inc. | $740.88M | $13.57 | 10.24% |
| MNMD | Mind Medicine (MindMed) Inc. | $728.33M | $9.64 | 3.12% |
| TNGX | Tango Therapeutics, Inc. | $724.07M | $6.68 | 1.33% |
| EYPT | EyePoint Pharmaceuticals, Inc. | $719.08M | $10.45 | 0.85% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $701.54M | $7.87 | 4.14% |
| MGTX | MeiraGTx Holdings plc | $690.34M | $8.59 | 1.15% |
| TSHA | Taysha Gene Therapies, Inc. | $687.82M | $2.63 | 4.16% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $677.65M | $2.53 | 6.30% |
| DAWN | Day One Biopharmaceuticals, Inc. | $665.95M | $6.57 | 2.66% |
| XNCR | Xencor, Inc. | $654.77M | $9.20 | 1.10% |
| GYRE | Gyre Therapeutics, Inc. | $653.04M | $7.23 | 1.83% |
| RLAY | Relay Therapeutics, Inc. | $636.06M | $3.71 | 2.20% |
| ZVRA | Zevra Therapeutics, Inc. | $633.19M | $11.58 | 1.28% |
| EMBC | Embecta Corp. | $624.75M | $10.69 | 3.89% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $624.44M | $11.45 | 1.87% |
| OMI | Owens & Minor, Inc. | $620.57M | $8.10 | 4.65% |
| EOLS | Evolus, Inc. | $617.03M | $9.57 | 3.80% |
| ORGO | Organogenesis Holdings Inc. | $611.44M | $4.82 | 5.70% |
| PRME | Prime Medicine, Inc. | $609.27M | $4.53 | 0.88% |
| ABUS | Arbutus Biopharma Corporation | $603.31M | $3.15 | 0.32% |
| ZBIO | Zenas BioPharma, Inc. | $598.65M | $14.31 | 0.14% |
| UPB | Upstream Bio, Inc. | $578.28M | $10.75 | 1.03% |
| KURA | Kura Oncology, Inc. | $577.45M | $6.67 | 3.09% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| KROS | Keros Therapeutics, Inc. | $557.65M | $13.73 | 0.44% |
| SEPN | Septerna, Inc. | $555.64M | $12.47 | 1.30% |
| ARVN | Arvinas, Inc. | $553.27M | $7.58 | 0.80% |
| PHAT | Phathom Pharmaceuticals, Inc. | $551.53M | $7.90 | 0.89% |
| SAGE | Sage Therapeutics, Inc. | $547.95M | $8.75 | 2.45% |
| TYRA | Tyra Biosciences, Inc. | $547.20M | $10.29 | 3.02% |
| FTRE | Fortrea Holdings Inc. | $524.90M | $5.80 | 24.46% |
| TERN | Terns Pharmaceuticals, Inc. | $524.03M | $6.00 | 6.38% |
| ZIMV | ZimVie Inc. | $522.97M | $18.73 | 0.16% |
| SIGA | SIGA Technologies, Inc. | $489.37M | $6.85 | 0.00% |
| TRML | Tourmaline Bio, Inc. | $484.49M | $18.86 | 3.46% |
| SLDB | Solid Biosciences Inc. | $482.92M | $6.23 | 2.20% |